Catalent

Catalent is a leading provider of advanced drug delivery solutions, specializing in biologics and pharmaceuticals. Their innovative OptiGel® Bio technology addresses the challenges of traditional intravenous drug delivery by enhancing the permeability of macromolecules and enabling targeted delivery through sophisticated enteric coating. This proprietary technology allows for the conversion of IV therapies to oral administration, improving patient adherence and comfort.

Catalent offers a wide range of services including drug substance and product development, analytical services, and comprehensive support in gene and cell therapies. Their capabilities extend to softgel formulation development, integrated manufacturing, and advanced bioconjugate solutions such as antibody-drug conjugates (SMARTag®). Backed by a strong intellectual property portfolio and extensive technical expertise, Catalent operates globally, with a network of CGMP-compliant facilities ready to customize solutions for successful product commercialization. With a commitment to innovation and excellence, Catalent is dedicated to advancing healthcare by delivering superior drug delivery systems and therapeutic solutions.